Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00657358 · ClinicalTrials.gov registry record · NA
The Effect of Intravenous Lidocaine on Normal Sensation and Pain in Healthy Volunteers
A NA study, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- NA
- Development phase
- 22
- Enrollment target
NCT00657358 is a NA study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 22 participants.
The verdict
NCT00657358, a NA study, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- NA
- Development phase
- 22 participants
- Enrollment target
Study Summary
The purpose of this study is to study if lidocaine, given intravenously, reduces pain.
Interventions
- DRUG Lidocaine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2008-04 |
| Est. Completion | 2012-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00657358
The ClinicalTrials.gov registry entry for NCT00657358 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Lidocaine is the first listed.
NCT00657358 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00657358 about?
NCT00657358 is a clinical study titled "The Effect of Intravenous Lidocaine on Normal Sensation and Pain in Healthy Volunteers". The purpose of this study is to study if lidocaine, given intravenously, reduces pain.
What is the current status of trial NCT00657358?
This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2008-04. Estimated completion is 2012-01.
What interventions are being tested in trial NCT00657358?
The interventions under investigation include: Lidocaine (DRUG).
Who is sponsoring clinical trial NCT00657358?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.